Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccination response in immunosuppressed patients with rheumatic autoimmune diseases
NL-OMON31399Withdrawn
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of influenza vaccine and Hepatitis B vaccine in influenza, pneumococcal disease and hepatitis B (HBV) (4 arms), sponsored by Radboud University Medical Center. Primary endpoints: Influenza antibody titer increase, Pneumococcal antibody titer increase and 1 more. Planned start Oct 2007; status: withdrawn.
02
Drugs
influenza vaccineHepatitis B vaccine
03
Conditions
influenzapneumococcal diseasehepatitis B (HBV)
Beyond the preview
Go deeper on NL-OMON31399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31399.